Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion | Zendy

Ethan Basch | Zendy; Thomas K. Oliver | Zendy; Andrew J. Vickers | Zendy; Ian M. Thompson | Zendy; Philip W. Kantoff | Zendy; Howard L. Parnes | Zendy; D.A. Loblaw | Zendy; Bruce J. Roth | Zendy; J. Koudy Williams | Zendy; Robert K. Nam | Zendy

Open Access

Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion

Author(s) -

Ethan Basch,

Thomas K. Oliver,

Andrew J. Vickers,

Ian M. Thompson,

Philip W. Kantoff,

Howard L. Parnes,

D.A. Loblaw,

Bruce J. Roth,

J. Koudy Williams,

Robert K. Nam

Publication year - 2012

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.43.3441

Subject(s) - medicine , prostate cancer , prostate cancer screening , prostate specific antigen , cancer , oncology , life expectancy , population , prostate biopsy , prostate , gynecology , clinical trial , intensive care medicine , environmental health

An American Society of Clinical Oncology (ASCO) provisional clinical opinion (PCO) offers timely clinical direction to the ASCO membership after publication or presentation of potentially practice-changing data from major studies. This PCO addresses the role of prostate-specific antigen (PSA) testing in the screening of men for prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research